According to the sources, the phase II human clinical trial of the Oxford COVID-19 vaccine candidate by the Serum Institute of India (SII), Pune will start from today. Bharati Vidyapeeth Medical College and Hospital in Pune is the site where this observer-blind, randomised controlled study to determine the safety and immunogenicity of Covishield on healthy Indian adults will be conducted.
As per the statement given by Prakash Kumar Sing....
Tags : Serum Institute of India, Covishield, SII, Oxford University, COVID-19 vaccine,
comments (0)